Michael King

Michael King News

  • Brokers Must Disclose Bonuses as Finra Passes Rule

    Stock brokers who are lured to new firms with signing bonuses of at least $100,000 will be required to inform clients under a rule approved by the Financial Industry Regulatory Authority.

  • Amgen Said to Boost Onyx Pharmaceuticals Bid to $130 a Share

    Amgen Inc., the drugmaker in pursuit of Onyx Pharmaceuticals Inc., boosted its offer for the company to $130 a share, according to a person familiar with the matter.

  • Obesity Prompts Vivus Takeover Talk With 88% Windfall: Real M&A

    Vivus Inc.’s shareholders are poised to reap an 88 percent windfall in a takeover after the company’s weight-loss drug moved one step closer to winning approval to treat America’s 78 million obese adults.

  • Nomura Code Viability Said to Be Under Review by Parent

    Nomura Holdings Inc. is reviewing the financial viability of Nomura Code Securities Ltd., the Japanese bank’s U.K. brokerage specializing in health and clean- technology companies, said a person with knowledge of the matter.

  • Alnylam Gains on Treatment Data for Deadly Nerve Disease

    Alnylam Pharmaceuticals Inc., the developer of a treatment for a rare genetic disorder, rose the most ever after the drug showed promise in an early clinical trial.

  • Pharmacyclics Drops Before J&J Earnings: San Francisco Mover

    Pharmacyclics Inc., the developer of blood cancer treatments with Johnson & Johnson, fell the most since April 10 ahead of Johnson & Johnson earnings scheduled for release tomorrow.

  • Onyx Snubbing Amgen Paves Way for 89% Premium: Real M&A

    Onyx Pharmaceuticals Inc., which surged more than 50 percent after rejecting a bid from Amgen Inc., is betting that potential suitors from Bayer AG to Bristol-Myers Squibb Co. are willing to offer even more.

  • Vivus Pill Promising Faster-Than Viagra Erection Approved

    A Vivus Inc. pill that is supposed to provide erections within 15 minutes, about half the time or less than Pfizer Inc.’s Viagra, won U.S. regulatory approval.

  • Prostate-Cancer Test May Reduce Repeat Biopsies: Study

    A new gene-based test for prostate cancer may reduce the need to repeat painful biopsies that can also cause serious infections, according to a study to be published in the Journal of Urology.

  • $50 Steaks and DVDs Make Tokyo Most Expensive for Foreigners as Yen Rises

    Tokyo, Japan's busy center of government, culture, and the economy, has been an expensive place to live for decades. Going to a movie theater costs about $22 per ticket, and renting a two-bedroom apartment easily costs $5,000 per month. Even travelers pay about $50 per night to sleep in capsule hotels, where guests stay in a "room" measuring about 2 meters (6 ft., 7 in.) deep, 1 meter wide, and 1 meter tall. As the yen has strengthened against the dollar, from 110 yen in August 2008 to about 90 yen to the U.S. dollar this month, the cost of living for foreign nationals paid in U.S. dollars has become tangibly more expensive in Tokyo.

Sponsored Links
Curation software by Lingospot